{"abstract":"The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 2-fluorodeschloroketamine.","action":"Proposed amendment; notice of intent.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/01/20/2026-00954.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1308,"title":21}],"citation":"91 FR 2323","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"January 20, 2026.","disposition_notes":null,"docket_ids":["Docket No. DEA-1442"],"dockets":[{"supporting_documents":[{"title":"DEA-1442 DEA Letter to HHS 05282025","document_id":"DEA-2026-0133-0006"},{"title":"DEA-1442 HHS Letter to DEA 11082024","document_id":"DEA-2026-0133-0005"},{"title":"DEA-1442 HHS Letter to DEA 06112025","document_id":"DEA-2026-0133-0004"},{"title":"DEA-1442 DEA Letter to HHS 11012024","document_id":"DEA-2026-0133-0003"},{"title":"DEA-1442 3-Factor Analysis 2-Fluorodeschloroketamine January 2026","document_id":"DEA-2026-0133-0002"}],"agency_name":"DEA","documents":[{"comment_count":0,"comment_start_date":"2026-01-20","updated_at":"2026-01-20T13:55:54.148-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2026-0133-0001","allow_late_comments":false,"id":"DEA-2026-0133-0001","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":5,"id":"DEA-2026-0133","title":"Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442)"}],"document_number":"2026-00954","effective_on":null,"end_page":2327,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/01/20/2026-00954.xml","html_url":"https://www.federalregister.gov/documents/2026/01/20/2026-00954/schedules-of-controlled-substances-temporary-placement-of-2-fluorodeschloroketamine-in-schedule-i","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-00954?publication_date=2026-01-20","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-01-20/2026-00954/mods.xml","not_received_for_publication":null,"page_length":5,"page_views":{"count":881,"last_updated":"2026-04-04 12:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-20/pdf/2026-00954.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-00954.pdf?1768571116","publication_date":"2026-01-20","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/01/20/2026-00954.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"DEA-1442 DEA Letter to HHS 05282025","document_id":"DEA-2026-0133-0006"},{"title":"DEA-1442 HHS Letter to DEA 11082024","document_id":"DEA-2026-0133-0005"},{"title":"DEA-1442 HHS Letter to DEA 06112025","document_id":"DEA-2026-0133-0004"},{"title":"DEA-1442 DEA Letter to HHS 11012024","document_id":"DEA-2026-0133-0003"},{"title":"DEA-1442 3-Factor Analysis 2-Fluorodeschloroketamine January 2026","document_id":"DEA-2026-0133-0002"}],"comments_count":0,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2026-0133","supporting_documents_count":5,"docket_id":"DEA-2026-0133","document_id":"DEA-2026-0133-0001","regulation_id_number":null,"title":"Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442)","checked_regulationsdotgov_at":"2026-01-21T22:55:04Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":2323,"subtype":null,"title":"Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I","toc_doc":"Temporary Placement of 2-Fluorodeschloroketamine in Schedule I","toc_subject":"Schedules of Controlled Substances","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":91}